Apple’s patent battle with Masimo is much from over. Because it stands proper now, Apple continues to be promoting the Apple Watch Collection 9 and Extremely 2 in america, however with the contested blood oxygen characteristic disabled.

In a brand new interview immediately, Apple CEO Tim Cook dinner indicated that Apple has no real interest in licensing Masimo’s know-how and placing the battle to relaxation. As an alternative, he stated that Apple is targeted on its attraction of the ITC’s ruling.

In an interview with CNBC following the discharge of Apple’s fiscal Q1 2024 earnings, Cook dinner stated there are a selection of causes for somebody to purchase the Apple Watch apart from the blood oxygen characteristic.

“We’re centered on attraction,” Cook dinner stated in a press release noticed by AppleInsider. “There’s a number of causes to purchase the watch even with out the blood oxygen sensor.”

The Apple Watch Collection 9 and Extremely 2 had been briefly pulled from Apple’s web site and retail shops in December. For fiscal Q1 2024, Apple’s Wearables, Dwelling, and Equipment class reported $11.95 billion in income, beating expectations of $11.39 billion.

Masimo CEO Joe Kiani stated prior to now that Apple has but to interact in “severe discussions a few settlement” with Masimo. In different interviews, Kiani stated that Masimo is open to a settlement with Apple, however “it takes two to tango.”

In the interim, you possibly can nonetheless purchase an Apple Watch Collection 9 and Apple Watch Extremely 2 from third-party retailers like Greatest Purchase and Amazon, and they’ll nonetheless have the blood oxygen app and options.